PPARgamma agonist rosiglitazone enhances the antiproliferative and anti-angiogenic profile of metronomic vinorelbine chemotherapy (Journal article)

Biziota, E./ Briasoulis, E./ Mavroeidis, L./ Marselos, M./ Pappas, P.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19174
ISSN: 1359-6349
Link: <Go to ISI>://000288603100271
http://ac.els-cdn.com/S1359634910710831/1-s2.0-S1359634910710831-main.pdf?_tid=b414db4791ff93034dd893ee05759c17&acdnat=1333004057_81800dd4b3e511392e7d4114b963d5db
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Biziota-2010-PPARgamma agonist ro.pdf66.56 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19174
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.